Drug Profile
LEO 27989
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator LEO Pharma
- Class Antipsoriatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Plaque psoriasis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Plaque-psoriasis in France (Topical, Ointment)
- 24 Feb 2011 Phase-I clinical trials in Plaque psoriasis in France (Topical)